Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Trends and Insights: Global Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Robot-Assisted Percutaneous Coronary Intervention (PCI) Market covering 2026–2035?
The market size for robot-assisted percutaneous coronary intervention (PCI) has shown substantial growth in recent years. This market is forecasted to increase from $27.56 billion in 2025 to $38.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 40.5%. The expansion observed historically can be credited to factors such as the rising prevalence of coronary artery disease, the precision limitations of manual PCI procedures, the increasing application of catheter-based interventions, a greater understanding of radiation risks, and the establishment of more cardiac catheterization labs.
The market for robot-assisted percutaneous coronary intervention (pci) is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $149.68 billion, advancing at a compound annual growth rate (CAGR) of 40.2%. During the projected period, this expansion is fueled by progress in robotic-assisted intervention techniques, the increased integration of automation within cardiology, greater financial commitments to digital healthcare frameworks, a heightened need for intricate and risky pci operations, and favorable regulatory endorsements for robotic platforms. Significant trends anticipated throughout the forecast period encompass the increasing acceptance of minimally invasive cardiac surgeries, a stronger emphasis on minimizing radiation exposure for medical professionals, a surging requirement for exactness and accuracy in procedures, the broadening of capabilities for complex coronary interventions, and enhanced patient well-being along with better clinical results.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27408&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
The rising occurrence of heart and blood vessel conditions is anticipated to fuel the expansion of the robot-assisted percutaneous coronary intervention (PCI) market moving ahead. These conditions encompass a range of ailments affecting the heart and vascular system, such as coronary artery disease, myocardial infarctions, and cerebrovascular accidents. An increase in cardiovascular diseases is primarily attributed to inactive lifestyles, resulting in weight gain, high blood pressure, and suboptimal cardiac well-being. Robot-assisted percutaneous coronary intervention (PCI) addresses cardiovascular diseases by precisely clearing obstructed or constricted coronary arteries, thereby re-establishing blood circulation to the heart, while minimizing procedural hazards and radiation exposure, leading to improved patient results. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England—about 4.4% of those aged 18 and over—had a GP-recorded diagnosis of CKD. This reflected an increase from 2.09 million cases the previous year. Consequently, the growing incidence of cardiovascular diseases is propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.
What Segments Are Identified Within The Structure Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –
1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles
2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy
3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems
2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters
3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels
What Trends Are Expected To Impact The Competitive Landscape Of The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are concentrating on developing sophisticated robotic cardiologist platforms to enhance patient safety and streamline complex coronary interventions. A robotic cardiology platform is an advanced technological system that assists cardiologists in performing precise and controlled coronary procedures, boosting accuracy, minimizing human error, and reducing radiation exposure for both patients and medical staff. For instance, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, launched the R-One+. This advanced robotic solution empowers interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by manipulating devices through an integrated command unit located in the catheterization lab or control room. The R-One+ increases precision in device handling, improves safety for patients and medical staff by decreasing radiation exposure, and provides more comfortable working conditions for operators. The launch occurred at the EuroPCR conference in Paris, where the platform demonstrated new capabilities that simplify and secure PCI procedures while protecting the cardiology team from radiation-induced injuries. This innovation highlights Robocath’s dedication to advancing cardiovascular disease treatments with intelligent robotic assistance.
Which Major Firms Are Strengthening Their Position In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market?
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In The Coming Years?
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27408&type=smp
Browse Through More Reports Similar to the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market 2026, By The Business Research Company
Post Consumer Recycled Plastics Global Market Report 2026
Plastic Recycling Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/plastic-recycling-global-market-report
Asphalt Shingles Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
